ArticleBMC infectious diseases2026
Viral load suppression and associated factors following enhanced adherence counseling among people living with HIV/AIDS.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPersistent enhanced adherence counseling (EAC) is necessary to improve adherence and achieve viral load suppression, particularly for clients with a viral load above 1000 copies/ml. The main aim of the study is to assess the magnitude of viral load suppression after EAC and associated factors among ART clients.
methodsA retrospective study was conducted using institutionally recorded data from July 2018 to June 2023. The study incorporated 409 records of people living with HIV (PLHIV) who were enrolled in EAC. They were selected using the random sampling technique. Data were collected using the Kobo Collect toolbox, and Stata 14.1 software was used for the analysis of exported data. Using binary logistic regression, the contributing components were identified. Variables with a p-value less than 0.25 during crude analysis were included in the multivariable logistic regression. Then, an odds ratio with 95% CI was utilized, and a p-value < 5% was used to identify factors.
resultViral load suppression rate after EAC were 64.3%, with a 95% CI (59.3-68.5). Experiencing poor drug adherence (AOR 0.21, 95% CI = 0.117-0.41), being a single (AOR 0.330, 95% CI = 0.18-0.63), being in rural resident (AOR 0.35, 95% CI = 0.202-0.60), having a history of alcohol consumption (AOR 0.53, 95% CI 0.286-0.98), and chewing khat (AOR 0.22, 95% CI = 0.09-0.54) were affecting the viral load suppression in this study.
conclusionThe unsuppressed viral load after EAC was associated with alcohol usage, khat chewing, marital status, poor adherence, and place of residence. The WHO target of 70% viral load suppression was not met. Thus, this study recommends that case managers, adherence counselors, and multidisciplinary teams at medical facilities prioritize clients with low adherence and address behavioral variables to optimize viral load suppression. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.